DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Goldstein D, Gofrit O, Nyska A. et al.
Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer.
Cancer Research 2007;
67: 269-275
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.